 |
|
|
| |
The Impact of Ribavirin on Real World Adherence and Discontinuation
Rates in HCV Patients Treated with Sofosbuvir + Simeprevir
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
David R Walker1, Timothy R Juday1, Shivaji R Manthena2, Yonghua Jing2, Vipan Sood1
1Global Health Economics & Outcomes Research, AbbVie, North Chicago, IL, USA; 2Health Economics & Outcomes Research, AbbVie, North Chicago, IL, USA
|
| |
|
|
|
|
|
